{"name":"Instituto de Oftalmología Fundación Conde de Valenciana","slug":"instituto-de-oftalmolog-a-fundaci-n-conde-de-valenciana","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":5,"colorKey":"oncology","drugs":[{"name":"Topical lyophilized exosomes application","genericName":"Topical lyophilized exosomes application","slug":"topical-lyophilized-exosomes-application","indication":"Ocular surface disease and corneal wound healing","status":"marketed"},{"name":"Duosomal chemical peel application","genericName":"Duosomal chemical peel application","slug":"duosomal-chemical-peel-application","indication":"Other","status":"marketed"},{"name":"Intralesional administration of 5-fluorouracil","genericName":"Intralesional administration of 5-fluorouracil","slug":"intralesional-administration-of-5-fluorouracil","indication":"Other","status":"marketed"},{"name":"Besifloxacin Ophthalmic","genericName":"Besifloxacin Ophthalmic","slug":"besifloxacin-ophthalmic","indication":"Other","status":"marketed"},{"name":"Nepafenac and lubricant","genericName":"Nepafenac and lubricant","slug":"nepafenac-and-lubricant","indication":"Other","status":"marketed"}]}],"pipeline":[{"name":"Topical lyophilized exosomes application","genericName":"Topical lyophilized exosomes application","slug":"topical-lyophilized-exosomes-application","phase":"marketed","mechanism":"Lyophilized exosomes delivered topically to the eye promote tissue repair and regeneration through delivery of bioactive molecules and stimulation of endogenous healing pathways.","indications":["Ocular surface disease and corneal wound healing"],"catalyst":""},{"name":"Duosomal chemical peel application","genericName":"Duosomal chemical peel application","slug":"duosomal-chemical-peel-application","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Intralesional administration of 5-fluorouracil","genericName":"Intralesional administration of 5-fluorouracil","slug":"intralesional-administration-of-5-fluorouracil","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Besifloxacin Ophthalmic","genericName":"Besifloxacin Ophthalmic","slug":"besifloxacin-ophthalmic","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""},{"name":"Nepafenac and lubricant","genericName":"Nepafenac and lubricant","slug":"nepafenac-and-lubricant","phase":"marketed","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTE1XMDdpQm9JZUlCZ1pxM2NaRjY0QXBON2FldTM0a01ZQWgyRG1TT1g5cFlnbVZOSXJ6U3NWQTlwX3pvbDZuOWRoMlFOLWI3d2RsbWVzNVZFVk1QVlotUzQ1X0lReXpyY1p3Y0N6clNzTFd3UQ?oc=5","date":"2019-05-10","type":"pipeline","source":"Mexico Business News","summary":"Expanding Eye-Care Reach - Mexico Business News","headline":"Expanding Eye-Care Reach","sentiment":"neutral"}],"patents":[],"drugCount":5,"phaseCounts":{"marketed":5},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}